Clinical Trial Update: Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing chemoembolization with or without mixing chemotherapy with Lipiodol for unresectable hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED